
Porton Capital et al. back Microvisk
Porton Capital, Oxford Technology Management, New Hill, Midven, the Rainbow Seed Fund, Finance Wales and private investors have backed Microvisk Technologies in a third round of finance with £6m.
Microvisk has developed a medical diagnostic strip based on a Micro-Electro-Mechanical System. The sensor technology is placed in a tiny strip to monitor the blood clotting status of patients taking the drug Wafarin.
The Microvisk SmartStrip system will allow patients to carry out blood test at home or in a doctors surgery. The company is preparing to commence trials in the USA and Germany within the next six months. The researcher operates at two facilities in North Wales and Oxfordshire.
In previous investment rounds, Microvisk has received a total of £10.5m.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater